NEW YORK (TheStreet) -- CHANGE IN RATINGS
American Electric (AEP) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $46 price target. Estimates also boosted, given the company's new rate plan in Ohio.
Aflac (AFL) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. Company has little margin to take future credit losses.
Cisco Systems (CSCO) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $22 price target. Expect solid near-term results and guidance.
Forest Laboratories (FRX) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $37 price target. Hospira (HSP) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $38 price target. Int'l Flavors & Fragrances (IFF) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $65 price target. Interpublic (IPG) upgraded at Nomura from Neutral to Buy, Nomura said. Valuation call, based on a $13 price target. Allscripts (MDRX) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Valuation call, based on a $15 price target. NetApp (NTAP) downgraded at Cantor from Buy to Hold, Cantor Fitzgerald said. Company can continue to struggle with enterprise demand. $38 price target. Priceline.com (PCLN) downgraded at Lazard from Buy to Neutral, Lazard said. Company is facing increased competition and Europe remains slow. PulteGroup (PHM) upgraded at JP Morgan to Overweight, JP Morgan said. $15 price target. Housing fundamentals should continue to improve over the next 18 months. PPL Corp (PPL) upgraded at UBS to Buy from Neutral, UBS said. $31 price target. Cost savings initiative. Select Medical (SEM) downgraded at UBS to Neutral from Buy, UBS said. $14 price target. Reducing rating following strong rally. Salix Pharmaceuticals (SLXP) upgraded at Cantor to Buy, Cantor Fitzgerald said. $60 price target. Estimates also upped, as the company is cutting costs. Toll Brothers (TOL) downgraded at JP Morgan to Underweight, JP Morgan said. Valuation call, based on a $30 price target. Trimble (TRMB) rated new Buy at Lazard. $58 price target.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV